KLOW PEN (80mg)
KLOW is an advanced peptide blend combining KPV, GHK-Cu, BPC-157, and TB-500, designed for research into inflammatory pathways, tissue regeneration, collagen production, skin quality, and recovery. By combining four research peptides in one formulation, KLOW targets multiple biological pathways associated with inflammation, repair, and regeneration. While the individual peptides have been investigated separately to varying degrees, KLOW as a combined formulation has not been established as safe or effective in human clinical trials.
KPV – A short peptide fragment derived from α-MSH that has been investigated in preclinical research for its potential effects on inflammatory pathways and immune signalling.
GHK-Cu – A naturally occurring copper-binding peptide studied for its potential role in collagen synthesis, skin remodelling, wound-repair processes, and tissue regeneration.
BPC-157 – An experimental peptide investigated primarily in preclinical studies for its potential involvement in soft-tissue repair, angiogenesis, and regenerative pathways.
TB-500 – A synthetic peptide associated with thymosin beta-4 research and investigated for its potential role in cell migration, tissue remodelling, and repair processes.
Together, these peptides make KLOW a multi-pathway research blend of interest in studies involving inflammatory signalling, skin and connective tissue biology, tissue repair, and regenerative processes.
For research purposes only. Not established as a medicine or approved treatment for human use.
){kind=link}